Mathieu Gauthé

14PUBLICATIONS
17CO-AUTHORS
Deep learningPredictive and prognostic markersMolecular targetsCell physiologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 17, 2025
Deep-learning-based software versus experienced nuclear medicine physician to read [18F]-piflufolastat used for PSMA-PET/CT imaging in prostate cancer patients presenting with first biochemical recurrence: A comparative study of detection rate.

Mathieu Gauthé, Sona Balogova

|Nov 25, 2023
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: A Systematic Review (French ccAFU).

Amine Saouli, Alain Ruffion, Charles Dariane

|Sep 28, 2023
Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer.

Rie von Eyben, Manuela Andrea Hoffmann, Cigdem Soydal

|Feb 25, 2023
Correction: von Eyben et al. A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis. Cancers 2022, 14, 5461.

Rie von Eyben, Daniel S Kapp, Manuela Andrea Hoffmann

|Nov 11, 2022
A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis.

Rie von Eyben, Daniel S Kapp, Manuela Andrea Hoffmann

|Mar 25, 2022
PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers.

Diego Teyssonneau, Antoine Thiery-Vuillemin, Charles Dariane

Pageof 3

Frequent Collaborators

5 joint publications

Charles Dariane

5 joint publications

Gaëlle Fiard

5 joint publications

Guillaume Ploussard

3 joint publications

Murat Tuncel